1. Home
  2. TECH vs CWAN Comparison

TECH vs CWAN Comparison

Compare TECH & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • CWAN
  • Stock Information
  • Founded
  • TECH 1976
  • CWAN 2004
  • Country
  • TECH United States
  • CWAN United States
  • Employees
  • TECH N/A
  • CWAN N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • CWAN Computer Software: Prepackaged Software
  • Sector
  • TECH Health Care
  • CWAN Technology
  • Exchange
  • TECH Nasdaq
  • CWAN Nasdaq
  • Market Cap
  • TECH 7.8B
  • CWAN 7.3B
  • IPO Year
  • TECH 1989
  • CWAN 2021
  • Fundamental
  • Price
  • TECH $49.15
  • CWAN $23.84
  • Analyst Decision
  • TECH Buy
  • CWAN Buy
  • Analyst Count
  • TECH 10
  • CWAN 9
  • Target Price
  • TECH $73.44
  • CWAN $32.44
  • AVG Volume (30 Days)
  • TECH 2.3M
  • CWAN 3.5M
  • Earning Date
  • TECH 05-07-2025
  • CWAN 04-30-2025
  • Dividend Yield
  • TECH 0.65%
  • CWAN N/A
  • EPS Growth
  • TECH N/A
  • CWAN N/A
  • EPS
  • TECH 0.83
  • CWAN 1.71
  • Revenue
  • TECH $1,208,770,000.00
  • CWAN $475,948,000.00
  • Revenue This Year
  • TECH $8.19
  • CWAN $63.47
  • Revenue Next Year
  • TECH $8.61
  • CWAN $28.99
  • P/E Ratio
  • TECH $59.07
  • CWAN $14.01
  • Revenue Growth
  • TECH 4.72
  • CWAN 23.21
  • 52 Week Low
  • TECH $46.44
  • CWAN $17.42
  • 52 Week High
  • TECH $85.57
  • CWAN $35.71
  • Technical
  • Relative Strength Index (RSI)
  • TECH 44.74
  • CWAN 51.19
  • Support Level
  • TECH $46.35
  • CWAN $23.59
  • Resistance Level
  • TECH $54.40
  • CWAN $24.63
  • Average True Range (ATR)
  • TECH 2.17
  • CWAN 0.62
  • MACD
  • TECH 0.27
  • CWAN 0.28
  • Stochastic Oscillator
  • TECH 34.78
  • CWAN 66.88

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About CWAN Clearwater Analytics Holdings Inc.

Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.

Share on Social Networks: